Epi-Stop Nasal Gel/epistaxis pack

FDA 510(k) K230142 · Biomed Ent, Inc.

Substantially Equivalent

510(k) numberK230142

Submission

Device name
Epi-Stop Nasal Gel/epistaxis pack
Applicant
Biomed Ent, Inc.
San Antonio, TX, US
Received
January 18, 2023
Decision date
March 22, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LYA – Splint, Intranasal Septal
Device class
Class I (low risk)
Regulation
21 CFR 874.4780
Specialty
Ear, Nose, Throat

Other 510(k)s with product code LYA

510(k)DeviceApplicantDecision
K243655TurbAlignLYA · Traditional Spirair, Inc.07/11/2025SE
K213153SPIWay Endonasal Access GuideLYA · Special Spiway, LLC10/27/2021SE
K202623Novapak Nasal Sinus Packing and StentLYA · Traditional Medtronic Xomed12/08/2020SE
K181696ChitoZolveLYA · Traditional Gyrus Acmi, Inc.11/30/2018SE
K180141SPIWay Endonasal Access GuideLYA · Special Spiway, LLC02/16/2018SE
K170913Composite Removable Sinus Stent SystemLYA · Traditional Sts Medical12/15/2017SE
K172179Chitogel Endoscopic Sinus Surgery KitLYA · Traditional Chitogel, Ltd.10/17/2017SE
K153686SPIWay Endonasal Access GuideLYA · Special Spiway, LLC01/28/2016SE
K141816HemoporeLYA · Traditional Polyganics B.V.,10/23/2014SE
K141704Novashield Injectable Nasal Packing and StentLYA · Traditional Medtronic, Inc.10/06/2014SE

Questions and answers

When was Epi-Stop Nasal Gel/epistaxis pack cleared by the FDA?

Epi-Stop Nasal Gel/epistaxis pack (K230142) received a 510(k) decision of Substantially Equivalent on March 22, 2023, 63 days after the submission was received.

What is the product code of K230142?

The FDA product code is LYA – Splint, Intranasal Septal, a Class I (low risk) device regulated under 21 CFR 874.4780.